Literature DB >> 33968384

Challenges in Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver: A Pathologist's Perspective.

Dana Balitzer1,2, Sanjay Kakar1.   

Abstract

Entities:  

Year:  2021        PMID： 33968384      PMCID： PMC8087916          DOI： 10.1002/cld.1091

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  12 in total

1.  Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.

Authors:  Jian Yong Lei; Wen Tao Wang; Lu Nan Yan
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-02       Impact factor: 2.566

2.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

3.  Liver cancer biopsy--back to the future?!

Authors:  Michael Torbenson; Peter Schirmacher
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

4.  Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.

Authors:  Ijin Joo; Jeong Min Lee; Sang Min Lee; Jeong Sub Lee; Jin Young Park; Joon Koo Han
Journal:  J Magn Reson Imaging       Date:  2016-04-18       Impact factor: 4.813

Review 5.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

6.  The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.

Authors:  Gonzalo Sapisochin; Nicolas Goldaracena; Jerome M Laurence; Martin Dib; Andrew Barbas; Anand Ghanekar; Sean P Cleary; Les Lilly; Mark S Cattral; Max Marquez; Markus Selzner; Eberhard Renner; Nazia Selzner; Ian D McGilvray; Paul D Greig; David R Grant
Journal:  Hepatology       Date:  2016-06-30       Impact factor: 17.425

7.  Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion.

Authors:  Derek DuBay; Charbel Sandroussi; Lakhbir Sandhu; Sean Cleary; Markus Guba; Mark S Cattral; Ian McGilvray; Anand Ghanekar; Markus Selzner; Paul D Greig; David R Grant
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

8.  Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.

Authors:  Luca Di Tommaso; Giada Franchi; Young Nyun Park; Barbara Fiamengo; Annarita Destro; Emanuela Morenghi; Marco Montorsi; Guido Torzilli; Maurizio Tommasini; Luigi Terracciano; Luigi Tornillo; Raffaella Vecchione; Massimo Roncalli
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 9.  Intrahepatic cholangiocarcinoma: current perspectives.

Authors:  Stefan Buettner; Jeroen LA van Vugt; Jan Nm IJzermans; Bas Groot Koerkamp
Journal:  Onco Targets Ther       Date:  2017-02-22       Impact factor: 4.147

Review 10.  Contemporary role of liver biopsy in hepatocellular carcinoma.

Authors:  Zeno Sparchez; Tudor Mocan
Journal:  World J Hepatol       Date:  2018-07-27
View more
  1 in total

1.  Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.

Authors:  Sobia Zaidi; Richard Amdur; Xiyan Xiang; Herbert Yu; Linda L Wong; Shuyun Rao; Aiwu R He; Karan Amin; Daewa Zaheer; Raj K Narayan; Sanjaya K Satapathy; Patricia S Latham; Kirti Shetty; Chandan Guha; Nancy R Gough; Lopa Mishra
Journal:  Genes Cancer       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.